We are live on ! Find out more
SAVAW

Cassava Sciences, Inc. Warrant

Delisted

SAVAW was delisted on the 2nd of May, 2024.

55 hedge funds and large institutions have $4.2M invested in Cassava Sciences, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 55 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

731% more call options, than puts

Call options by funds: $1.4M | Put options by funds: $169K

Holders
55
Holders Change
+55
Holders Change %
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
55
Increased
Reduced
Closed
Calls
$1.4M
Puts
$169K
Net Calls
+$1.24M
Net Calls Change
+$1.24M

SAVAW Hedge Fund Activity: Q1 2024 in Review

55 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Cassava Sciences, Inc. Warrant (SAVAW) for Q1 2024, worth a combined $4.2M.

Buyers outnumbered sellers: 55 funds opened new SAVAW positions and 0 closed out — a net gain of 55 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Gallacher Capital Management, opening a new position worth an estimated $1.26M.

  • 55 institutional investors held Cassava Sciences, Inc. Warrant (SAVAW) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $4.2M of Cassava Sciences, Inc. Warrant stock for Q1 2024.
  • 55 funds opened new Cassava Sciences, Inc. Warrant positions in Q1 2024 and 0 closed out, a net change of +55 holders.
  • The largest Cassava Sciences, Inc. Warrant buyer in Q1 2024 was Gallacher Capital Management, an estimated $1.26M added.

Based on aggregated 13F filings for Q1 2024.